Literature DB >> 3519791

The role of complement and antibody in opsonophagocytosis of type II group B streptococci.

C J Baker, B J Webb, D L Kasper, M S Edwards.   

Abstract

The role of complement and antibody in the opsonophagocytosis of type II group B streptococci (type II GBS) was defined with sera from healthy adults and two populations with theoretical susceptibility to type II GBS infection--neonates and insulin-dependent diabetics. Significant opsonophagocytosis (bactericidal index, greater than or equal to 90%) of five clinical isolates of type II GBS lacking components of protein antigen c was demonstrated by each of 12 adult sera, as well as by agammaglobulinemic serum, a result indicating that opsonophagocytosis can proceed by antibody-independent activation of the classic complement pathway. Strains containing components of protein antigen c were somewhat more resistant to opsonin-binding activity. Four of 10 neonatal sera and nine of 15 diabetic sera exhibited inefficient opsonophagocytosis. Some of the adult sera with either high or low concentrations of specific antibody to type II GBS promoted opsonophagocytosis via the alternative complement pathway, but this response was not observed with neonatal sera. The addition of sufficient amounts of specific antibody to type II GBS to neonatal and adult diabetic sera in vitro, however, promoted efficient opsonophagocytosis via the alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3519791     DOI: 10.1093/infdis/154.1.47

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Influence of serotype of group B streptococci on C3 degradation.

Authors:  J R Campbell; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Group B Streptococcus necrotizing fasciitis: an emerging disease?

Authors:  C-H Wong; A Kurup; K-C Tan
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-06-16       Impact factor: 3.267

3.  Opsonic effect of jacalin and human immunoglobulin A on type II group B streptococci.

Authors:  N R Payne; N F Concepcion; B F Anthony
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

4.  Characterization of a novel leucine-rich repeat protein antigen from group B streptococci that elicits protective immunity.

Authors:  Ravin Seepersaud; Sean B Hanniffy; Peter Mayne; Phil Sizer; Richard Le Page; Jerry M Wells
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Nonimmune binding of human immunoglobulin A to type II group B streptococci.

Authors:  B F Anthony; N F Concepcion; S M Puentes; N R Payne
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

6.  Effect of differences in antibody and complement requirements on phagocytic uptake and intracellular killing of "c" protein-positive and -negative strains of type II group B streptococci.

Authors:  N R Payne; Y K Kim; P Ferrieri
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

7.  Protein X of Streptococcus agalactiae induces opsonic antibodies in cows.

Authors:  P Rainard; Y Lautrou; P Sarradin; B Poutrel
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

8.  Complement and antibody participation in opsonophagocytosis of type IV and V group B streptococci.

Authors:  M A Hall; M S Edwards; C J Baker
Journal:  Infect Immun       Date:  1992-12       Impact factor: 3.441

9.  Phenotypic diversity in the alpha C protein of group B streptococci.

Authors:  L C Madoff; S Hori; J L Michel; C J Baker; D L Kasper
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

10.  The Group B Streptococcus-Secreted Protein CIP Interacts with C4, Preventing C3b Deposition via the Lectin and Classical Complement Pathways.

Authors:  Giampiero Pietrocola; Simonetta Rindi; Roberto Rosini; Scilla Buccato; Pietro Speziale; Immaculada Margarit
Journal:  J Immunol       Date:  2015-11-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.